Ocumetics Technology Corp. (OTC)

Ocumetics Technology Corp. (OTC $0.40)
- $0.40 Cap: $46M
- View OTC Profile
- View Questions on OTC

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Ocumetics Technology Corp. (OTC $0.40)
- $0.40 Cap: $46M
- View OTC Profile
- View Questions on OTC

Q: how is this company doing some interesting tech do they have any competition thank you

Read Answer Asked by cindy on January 07, 2025

Ocumetics Technology Corp. (OTC $0.40)
- $0.40 Cap: $46M
- View OTC Profile
- View Questions on OTC

Q: 1. OTC has a design lockdown and is scheduled to begin animal trials this year.
2. It has also paid out 2 senior executives with Shares.

In your experience do you think a company letting executives go when it appears to be making progress on its research is an indicator it might be tendering a buyout? or do you think this is a sign the company is experiencing hardship and the research is not panning out?

Read Answer Asked by Marjorie on May 03, 2023